ArticleActa pharmaceutica Sinica. B2022

Engineering prodrug nanomicelles as pyroptosis inducer for codelivery of PI3K/mTOR and CDK inhibitors to enhance antitumor immunity.

Qichao Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.